12 Health Care Stocks Moving In Friday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
During Friday's pre-market session, several health care stocks experienced significant movement. Trxade Health, Novo Integrated Sciences, Axcella Health, 23andMe Holding, Virpax Pharmaceuticals, and Celularity saw gains, while Aditxt, Biodexa Pharmaceuticals, Acer Therapeutics, Aravive, Allarity Therapeutics, and Xtant Medical Hldgs experienced losses.
September 01, 2023 | 1:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Axcella Health's stock rose by 29.3% to $0.3.
The significant increase in Axcella Health's stock price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
Celularity's stock increased by 12.34% to $0.36.
The increase in Celularity's stock price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 50
RELEVANCE 100
POSITIVE IMPACT
23andMe Holding's stock rose by 19.54% to $1.31.
The significant increase in 23andMe Holding's stock price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
Trxade Health's stock rose by 99.2% to $15.22.
The significant increase in Trxade Health's stock price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Novo Integrated Sciences' shares rose by 50.71% to $0.21.
The significant increase in Novo Integrated Sciences' share price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Virpax Pharmaceuticals' shares increased by 13.66% to $0.98.
The increase in Virpax Pharmaceuticals' share price indicates positive investor sentiment, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 50
RELEVANCE 100
NEGATIVE IMPACT
Acer Therapeutics' shares decreased by 15.63% to $1.08.
The significant decrease in Acer Therapeutics' share price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Aditxt's stock declined by 45.7% to $29.87.
The significant decrease in Aditxt's stock price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Allarity Therapeutics' stock declined by 7.57% to $1.71.
The decrease in Allarity Therapeutics' stock price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 50
RELEVANCE 100
NEGATIVE IMPACT
Aravive's shares decreased by 8.93% to $0.14.
The decrease in Aravive's share price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 50
RELEVANCE 100
NEGATIVE IMPACT
Biodexa Pharmaceuticals' shares decreased by 16.65% to $6.66.
The significant decrease in Biodexa Pharmaceuticals' share price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Xtant Medical Hldgs' shares decreased by 7.5% to $1.11.
The decrease in Xtant Medical Hldgs' share price indicates negative investor sentiment, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 50
RELEVANCE 100